Medical Director MD, Clinical Development, Endocrinology
Neurocrine Biosciences
August 09, 2026
Remote friendly (San Diego, CA)
United States
Clinical Research and Development
About the Role
The Medical Director will advance clinical programs for endocrine and metabolic disorders by partnering with Clinical Operations, Regulatory Affairs, Drug Safety, Biometrics, Translational Medicine, Research, and Medical Affairs colleagues, providing scientific/medical expertise across study design, execution, safety evaluation, biomarker strategies, and data interpretation.
Your Contributions (include, But Are Not Limited To)
- Provide medical leadership for Phase 1–3 clinical studies within the endocrinology portfolio.
- Develop and implement clinical study protocols with multidisciplinary teams.
- Serve as Sponsor medical monitor; maintain relationships with investigators, study sites, and external experts.
- Review clinical safety data (adverse events and emerging safety signals) with Drug Safety.
- Partner with Clinical Operations to ensure compliance with GCP, applicable regulations, and company procedures.
- Analyze, interpret, and communicate clinical results to internal and external audiences.
- Prepare/review clinical study reports, regulatory documents, presentations, and publications.
- Support translational and biomarker strategy development and implementation.
- Collaborate with Medical Affairs and external experts to build scientific partnerships and communicate findings.
- Contribute to evaluation of new development opportunities and clinical development strategy discussions.
- Assist with study planning, resource forecasting, and engagement of consultants/CROs.
Requirements
- MD or DO with accredited residency training and board certification in relevant specialty AND 2+ years clinical research/development experience (Phase 1–4) in pharma/biotech or clinical research/academic environment.
- Strong clinical drug development, study design, and trial execution knowledge.
- Knowledge of GCP, regulatory requirements, and clinical development processes.
- Experience interpreting clinical/safety data and communicating findings.
- Understanding of translational medicine, biomarker development, and clinical pharmacology.
- Strong analytical/problem-solving and excellent communication/collaboration skills.
- Ability to work in a matrix environment and manage multiple priorities.
- Track record collaborating with CROs, investigators, consultants, and cross-functional teams.
Preferred Qualifications
- Board certification in Endocrinology.
- Endocrine/metabolic clinical development experience.
- Medical monitor or study physician experience.
- Early- and/or late-stage clinical development experience.
- Familiarity with regulatory interactions and clinical submission activities.
- Interest in advancing innovative therapies for endocrine disorders.
Benefits (if part of the job description)
- Retirement savings plan (company match), paid vacation/holiday/personal days, caregiver/parental and medical leave, and health benefits (medical, prescription drug, dental, vision).
- Annual bonus (target 35% of earned base salary) and equity-based long-term incentive eligibility.
The Medical Director will advance clinical programs for endocrine and metabolic disorders by partnering with Clinical Operations, Regulatory Affairs, Drug Safety, Biometrics, Translational Medicine, Research, and Medical Affairs colleagues, providing scientific/medical expertise across study design, execution, safety evaluation, biomarker strategies, and data interpretation.
Your Contributions (include, But Are Not Limited To)
- Provide medical leadership for Phase 1–3 clinical studies within the endocrinology portfolio.
- Develop and implement clinical study protocols with multidisciplinary teams.
- Serve as Sponsor medical monitor; maintain relationships with investigators, study sites, and external experts.
- Review clinical safety data (adverse events and emerging safety signals) with Drug Safety.
- Partner with Clinical Operations to ensure compliance with GCP, applicable regulations, and company procedures.
- Analyze, interpret, and communicate clinical results to internal and external audiences.
- Prepare/review clinical study reports, regulatory documents, presentations, and publications.
- Support translational and biomarker strategy development and implementation.
- Collaborate with Medical Affairs and external experts to build scientific partnerships and communicate findings.
- Contribute to evaluation of new development opportunities and clinical development strategy discussions.
- Assist with study planning, resource forecasting, and engagement of consultants/CROs.
Requirements
- MD or DO with accredited residency training and board certification in relevant specialty AND 2+ years clinical research/development experience (Phase 1–4) in pharma/biotech or clinical research/academic environment.
- Strong clinical drug development, study design, and trial execution knowledge.
- Knowledge of GCP, regulatory requirements, and clinical development processes.
- Experience interpreting clinical/safety data and communicating findings.
- Understanding of translational medicine, biomarker development, and clinical pharmacology.
- Strong analytical/problem-solving and excellent communication/collaboration skills.
- Ability to work in a matrix environment and manage multiple priorities.
- Track record collaborating with CROs, investigators, consultants, and cross-functional teams.
Preferred Qualifications
- Board certification in Endocrinology.
- Endocrine/metabolic clinical development experience.
- Medical monitor or study physician experience.
- Early- and/or late-stage clinical development experience.
- Familiarity with regulatory interactions and clinical submission activities.
- Interest in advancing innovative therapies for endocrine disorders.
Benefits (if part of the job description)
- Retirement savings plan (company match), paid vacation/holiday/personal days, caregiver/parental and medical leave, and health benefits (medical, prescription drug, dental, vision).
- Annual bonus (target 35% of earned base salary) and equity-based long-term incentive eligibility.